The total return over the past 12 months is +1.08% vs. +17.77% for the S&P 500. So far it's up +5.29% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +1.08% | +10.16% | +18.94% | +17.65% | +16.07% | +13.95% |
| Total Return CAGR | +1.08% | +10.16% | +18.94% | +17.65% | +16.07% | +13.95% |
| Revenue CAGR | +10.41% | +10.00% | +13.82% | +25.23% | +31.81% | +23.80% |
| Net Income CAGR | N/A | +9.99% | +9.45% | +29.85% | N/A | N/A |
| EPS CAGR | +4.89% | +6.03% | +8.17% | +39.93% | N/A | N/A |
| Free Cash Flow CAGR | N/A | (1.57%) | +4.01% | +56.82% | N/A | N/A |
| Operating Cash Flow CAGR | N/A | +1.35% | +4.77% | +36.56% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Vertex Pharmaceuticals Incorporated (VRTX)
| Year | Start Value | End Value | VRTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 3555.76 | 3744.00 | +5.29% | +8.94% | (3.65%) |
| 2025 | 3158.43 | 3555.76 | +12.58% | +17.72% | (5.14%) |
| 2024 | 3191.29 | 3158.43 | (1.03%) | +24.89% | (25.92%) |
| 2023 | 2264.94 | 3191.29 | +40.90% | +26.19% | +14.71% |
| 2022 | 1722.35 | 2264.94 | +31.50% | (18.17%) | +49.67% |
| 2021 | 1853.65 | 1722.35 | (7.08%) | +28.74% | (35.82%) |
| 2020 | 1717.25 | 1853.65 | +7.94% | +18.37% | (10.43%) |
| 2019 | 1299.69 | 1717.25 | +32.13% | +31.22% | +0.91% |
| 2018 | 1175.37 | 1299.69 | +10.58% | (4.56%) | +15.14% |
| 2017 | 577.80 | 1175.37 | +103.42% | +21.70% | +81.72% |
